Daytime urinary incontinence in a previously continent child (secondary incontinence) or persistent incontinence beyond the expected age of continence (primary incontinence) is one of the most common paediatric presentations in UK primary care — affecting approximately 15% of 5-year-olds and 5% of 10-year-olds. The critical diagnostic distinction is between primary daytime incontinence (the child has never achieved reliable daytime dryness) and secondary daytime incontinence (new onset after a period of dryness). Secondary incontinence is a red flag requiring investigation for: UTI, constipation, emotional stress, sexual abuse, diabetes mellitus, and neurological or anatomical causes. Primary daytime incontinence beyond age 5 most commonly results from overactive bladder (OAB) or dysfunctional voiding — both highly treatable conditions. The GP's role is to identify the dangerous causes, then manage or refer appropriately for the common functional causes.

The functional bladder capacity formula (age in years + 2) × 30 ml is a useful clinical reference — a 5-year-old has an expected functional bladder capacity of approximately (5+2)×30 = 210 ml, and a 10-year-old approximately (10+2)×30 = 360 ml. Children with overactive bladder (OAB) typically void smaller volumes more frequently than expected for their age. Bladder diaries (a 2-day recording of all fluid intake, void times, void volumes, and incontinence episodes) are the gold standard assessment tool and are entirely achievable at home with simple equipment (a measuring jug in the bathroom). The ERIC (Education and Resources for Improving Childhood Continence) charity provides free downloadable bladder diary forms and is an excellent resource for GPs and families. Bladder diaries allow the GP or nurse to distinguish between: OAB (small frequent voids with urgency), voiding dysfunction (infrequent large voids with urgency and incomplete emptying), and normal voiding with access problems (adequate bladder capacity, normal frequency, just not reaching the toilet in time).

The bladder diary is one of the most valuable and underused assessment tools in paediatric incontinence — it takes 2 days to complete, costs nothing, and provides information about voiding frequency, voided volumes, fluid intake, and incontinence episodes that cannot be obtained any other way. The practical approach: provide the family with a simple recording chart (the ERIC charity's bladder diary is freely downloadable at eric.org.uk), a measuring jug for the bathroom, and instructions. Ask them to complete it over one weekend and one school day. The results will immediately identify: whether the child is drinking enough (many children are significantly dehydrated, with 2-4 voids per day instead of 6-8 — concentrated urine is a bladder irritant that worsens OAB); whether the voids are small and frequent (OAB pattern) or large and infrequent (voiding postponement/dysfunctional voiding); and whether the incontinence pattern correlates with urgency or occurs without warning. Without a bladder diary, the GP is working blind.

The constipation-bladder connection is one of the most important and most overlooked relationships in paediatric incontinence — approximately 30-50% of children with daytime urinary incontinence have significant constipation, and in many children, treating the constipation alone resolves the urinary symptoms completely. The anatomical mechanism: the loaded sigmoid colon and rectum lie immediately posterior to the bladder, and significant faecal loading mechanically compresses the bladder, reducing functional capacity and triggering premature detrusor contractions. The neurological mechanism: the sacral nerve roots (S2-S4) supply both the rectum/anal sphincter and the bladder/urethral sphincter — chronic rectal distension from constipation impairs normal bladder afferent signalling. The practical message: every child presenting with daytime urinary incontinence should have constipation actively assessed and aggressively treated before any bladder-specific pharmacological treatment is initiated. The Bristol Stool Chart is a useful tool for assessing stool consistency with children.

The referral to a paediatric continence nurse specialist is frequently the most appropriate and cost-effective first-line referral for functional daytime incontinence in primary care — these specialist nurses (increasingly available across UK NHS trusts and community services) have the time, expertise, and tools (bladder diary analysis software, uroflowmetry in some centres, reward chart and behaviour modification resources) to manage the majority of OAB and voiding postponement cases without requiring a paediatrician consultation. The NICE guideline NG111 (Bedwetting in Under 19s) and the ERIC charity both emphasise that the vast majority of childhood incontinence is manageable in community settings with nurse specialist support. GPs should check their local ICB continence service directory for the referral pathway. Paediatric urology should be reserved for structural abnormalities, refractory cases, and secondary incontinence with an identified organic cause.

The Movicol Paediatric disimpaction regimen is the NICE-recommended first-line treatment for faecal impaction in children — but it requires careful patient and parent education to succeed. Many parents are alarmed by the escalating dose regimen (up to 8 sachets per day) and the liquid stool that indicates successful disimpaction. Clear written instructions are essential: explain that the goal is to soften and clear the impacted stool, that the liquid stool (overflow) they may have seen from their child is a sign of severe constipation rather than diarrhoea, and that successful disimpaction means the child passes a large, soft, messy stool. After disimpaction, maintenance laxative therapy at lower doses (1-2 sachets daily) must continue for at least 3-6 months — and often 12-24 months in chronic constipation. The most common reason for treatment failure in paediatric constipation is premature cessation of maintenance laxatives as soon as the child appears improved, followed by rapid reimpaction. Lactulose (second choice if macrogol not tolerated): 2.5-10 ml BD in under-5s, 5-20 ml BD in older children.

Oxybutynin is an effective treatment for paediatric OAB but its side-effect profile deserves specific attention in the context of constipation — constipation is both a cause of OAB (loaded bowel compressing the bladder) and a side effect of oxybutynin (anticholinergic effects reduce bowel motility). Starting oxybutynin without treating concurrent constipation will worsen the constipation, worsen the bladder symptoms, and create a vicious cycle. The correct approach: treat constipation first, achieve adequate bowel function, then reassess OAB symptoms (which may have resolved with constipation treatment alone). If OAB persists after constipation is treated: start oxybutynin — but simultaneously intensify constipation treatment to counteract the anticholinergic bowel effect. Co-prescribing macrogol laxative alongside oxybutynin is standard practice in paediatric urology. At every review of a child on oxybutynin: ask specifically about constipation and stool frequency — if constipating, increase macrogol dose.

The Equality Act 2010 protection for children with bladder and bowel conditions is an important advocacy tool that GPs can deploy — incontinence (when it meets the definition of a disability: a physical impairment with substantial long-term adverse effect on day-to-day activities) is covered by the Equality Act, and schools have a legal duty to make reasonable adjustments. In practice, many schools continue to deny children toilet access during lesson times, refuse to allow spare clothes to be kept in school, or embarrass children by requiring them to ask permission in front of classmates. A GP letter to the school requesting specific adjustments (unrestricted access, spare clothes, teacher briefing, IHP) has significant practical impact on the child's quality of life and treatment success. The ERIC charity provides a free template school letter for GPs to use, which can be personalised to the individual child.

The long-term outcomes for childhood daytime urinary incontinence are genuinely encouraging — the majority of children with OAB who receive appropriate treatment (bladder retraining + constipation management + oxybutynin if needed) achieve reliable daytime continence by the age of 10-12 years. This positive prognosis should be communicated explicitly to families who are often anxious about long-term implications. The important caveats: (1) dysfunctional voiding with VUR and renal scarring requires long-term nephrology monitoring because VUR-associated reflux nephropathy can cause chronic kidney disease and hypertension in adulthood even after the voiding pattern has normalised; (2) children with an underlying neurological cause (tethered cord, spinal dysraphism) may have persistent bladder dysfunction requiring lifelong urological management; and (3) DLD and ASD are commonly associated with continence difficulties that persist longer than in neurotypical children and require adapted approaches.